|
|
Name of Company | Shasun Chemicals and drugs |
BSE Code | 524552 |
NSE Code | SHASUNCHEM |
ICICI Code | |
Established | 1976 |
My Take | Like |
Headquarters | Chennai |
Promoters |
|
Story | Service segment of Pharma – manufactures API's, contract research, contract manufacturing, contract synthesis, contract formulation. |
Sector | Pharma |
Sub-sector | API's, intermediaries, enteric coating excipients |
Website | |
Positives | Market cap of 350 Cr at a price of Rs. 70. Buy below Rs. 40. FY10 seems would end on a positive note. Revenues have been growing from FY05. FY10 also seems to end with more revenues. They are focusing on the research by acquiring firms that have good research facility and offshoring research to bring down costs. One of the largest producers of ibuprofen, rantidine, nizatidine worldwide. |
Negatives | FY08 profits had come down Rs. 22 Cr even though revenues had gone up to 481 Cr. FY09 ended with a net loss of 33 Cr. Interest payment also has increased in FY09 to 12 Cr. The acquisition of Rhodia group and its UK operations are being a drag- it needs to be seen if currency related losses and operating a company at UK can be handled by the company. |
Peers |
|
Search This Blog
Apr 25, 2010
Shasun Chemicals and drugs 524552
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment